Developing and Evaluating a Measure of the Willingness to Use Pandemic-Related mHealth Tools Using National Probability Samples in the United States: Quantitative Psychometric Analyses and Tests of Sociodemographic Group Differences.

BACKGROUND: There are no psychometrically validated measures of the willingness to engage in public health screening and prevention efforts, particularly mobile health (mHealth)-based tracking, that can be adapted to future crises post-COVID-19. OBJECTIVE: The psychometric properties of a novel measure of the willingness to participate in pandemic-related screening and tracking, including the willingness to use pandemic-related mHealth tools, were tested. METHODS: Data were from a cross-sectional, national probability survey deployed in 3 cross-sectional stages several weeks apart to adult residents of the United States (N=6475; stage 1 n=2190, 33.82%; stage 2 n=2238, 34.56%; and stage 3 n=2047, 31.62%) from the AmeriSpeak probability-based research panel covering approximately 97% of the US household population. Five items asked about the willingness to use mHealth tools for COVID-19-related screening and tracking and provide biological specimens for COVID-19 testing. RESULTS: In the first, exploratory sample, 3 of 5 items loaded onto 1 underlying factor, the willingness to use pandemic-related mHealth tools, based on exploratory factor analysis (EFA). A 2-factor solution, including the 3-item factor, fit the data (root mean square error of approximation [RMSEA]=0.038, comparative fit index [CFI]=1.000, standardized root mean square residual [SRMR]=0.005), and the factor loadings for the 3 items ranged from 0.849 to 0.893. In the second, validation sample, the reliability of the 3-item measure was high (Cronbach α=.90), and 1 underlying factor for the 3 items was confirmed using confirmatory factor analysis (CFA): RMSEA=0, CFI=1.000, SRMR=0 (a saturated model); factor loadings ranged from 1.000 to 0.962. The factor was independently associated with COVID-19-preventive behaviors (eg, "worn a face mask": r=0.313, SE=0.041, P<.001; "kept a 6-foot distance from those outside my household": r=0.282, SE=0.050, P<.001) and the willingness to provide biological specimens for COVID-19 testing (ie, swab to cheek or nose: r=0.709, SE=0.017, P<.001; small blood draw: r=0.684, SE=0.019, P<.001). In the third, multiple-group sample, the measure was invariant, or measured the same thing in the same way (ie, difference in CFI [ΔCFI]<0.010 across all grouping categories), across age groups, gender, racial/ethnic groups, education levels, US geographic region, and population density (ie, rural, suburban, urban). When repeated across different samples, factor-analytic findings were essentially the same. Additionally, there were mean differences (ΔM) in the willingness to use mHealth tools across samples, mainly based on race or ethnicity and population density. For example, in SD units, suburban (ΔM=-0.30, SE=0.13, P=.001) and urban (ΔM=-0.42, SE=0.12, P<.001) adults showed less willingness to use mHealth tools than rural adults in the third sample collected on May 30-June 8, 2020, but no differences were detected in the first sample collected on April 20-26, 2020. CONCLUSIONS: Findings showed that the screener is psychometrically valid. It can also be adapted to future public health crises. Racial and ethnic minority adults showed a greater willingness to use mHealth tools than White adults. Rural adults showed more mHealth willingness than suburban and urban adults. Findings have implications for public health screening and tracking and understanding digital health inequities, including lack of uptake.

Moderate support for the use of digital tracking to support climate-mitigation strategies.

The use of digital tracking of individuals throughout the coronavirus 2019 (COVID-19) pandemic renewed societal debates on the efficacy and ethics of digital surveillance to mitigate collective crises. While digital emissions tracking is being used to support climate-mitigation strategies, to date there has been limited exploration of the opportunities and challenges of deploying it at the individual level. Here, we assess temporal and regional differences in levels of support for the use of digital surveillance in times of crisis, such as climate change. Results from a global survey indicate moderate support for the use of digital tracking, including for personal carbon footprints. Response varied regionally, with the lowest support in North America and Europe. This study raises key questions-if digital surveillance tools could be part of a socially acceptable response to the climate crisis, is it worth exploring? Or is this an unacceptable risk for society?

PREVENTION OF THE STIGMATIZATION OF INDIVIDUALS IN RESPONSE TO DIGITAL TRACKING (CONCIDERING COVID-19 ISSUE).

OBJECTIVE: The aim of the research is to identify possible manifestations of the stigmatization of individuals stemming from the use of digital applications while conducting anti-epidemic measures in Ukraine and developing measures to prevent stigmatization caused by the introduction of such applications. PATIENTS AND METHODS: Materials and methods: The study is grounded on dialectical, analytic, synthetic, comparative, statistic, sociological and criminological research methods. More than 120 citizens were interviewed to find out their attitude to Act at Home mobile application. The calculations were performed with the use of Excel spreadsheets of Microsoft Office 2016. The theoretical basis of the article is the specialized literature on medicine, law and computer science. RESULTS: Results: The paper substantiates the connection of the mechanism for the prevention of stigmatization of people who use mobile applications to track their contacts in the conditions of COVID-19 with the positive and negative obligations of member states of the Council of Europe on insuring of non-interference in private and family life. A system of general and special means of prevention of this antisocial phenomenon has been developed. The authors also identify the requirements for mobile applications that could reduce the risk of stigma. CONCLUSION: Conclusion: The conclusions suggest the ways of further prevention of stigmatization of people who use mobile applications to track their contacts. The paper outlines the content of the positive and negative obligations of the member states of the Council of Europe to ensure non-interference in the private and family life of citizens who are under observation or self-isolation due to COVID-19 pandemic.

COVID-19 Diagnostics, Tools, and Prevention.

The Coronavirus Disease 2019 (COVID-19), caused by the severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2), outbreak from Wuhan City, Hubei province, China in 2019 has become an ongoing global health emergency. The emerging virus, SARS-CoV-2, causes coughing, fever, muscle ache, and shortness of breath or dyspnea in symptomatic patients. The pathogenic particles that are generated by coughing and sneezing remain suspended in the air or attach to a surface to facilitate transmission in an aerosol form. This review focuses on the recent trends in pandemic biology, diagnostics methods, prevention tools, and policies for COVID-19 management. To meet the growing demand for medical supplies during the COVID-19 era, a variety of personal protective equipment (PPE) and ventilators have been developed using do-it-yourself (DIY) manufacturing. COVID-19 diagnosis and the prediction of virus transmission are analyzed by machine learning algorithms, simulations, and digital monitoring. Until the discovery of a clinically approved vaccine for COVID-19, pandemics remain a public concern. Therefore, technological developments, biomedical research, and policy development are needed to decipher the coronavirus mechanism and epidemiological characteristics, prevent transmission, and develop therapeutic drugs.